Fidelity Group of Funds > Fidelity Advisor Series VII
Fidelity Advisor Biotechnology Fund
$1.61B
Avg Monthly Net Assets
$1.98B
Total Assets
$170.36M
Total Liabilities
$1.81B
Net Assets
Fidelity Advisor Biotechnology Fund is a Mutual Fund in Fidelity Advisor Series VII
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has five share classes
and monthly net assets of $1.61B.
On September 25th, 2024 it reported 100 holdings, the largest
being ABBVIE INC (18.2%), AMGEN INC (9.4%) and Fidelity Revere Street Trust (9.1%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Fidelity Advisor Biotechnology Fund - Class A | C000014519 | FBTAX | |
| Fidelity Advisor Biotechnology Fund - Class C | C000014521 | FBTCX | |
| Fidelity Advisor Biotechnology Fund - Class I | C000014523 | FBTIX | |
| Fidelity Advisor Biotechnology Fund - Class M | C000014522 | FBTTX | |
| Fidelity Advisor Biotechnology Fund - Class Z | C000204999 | FIJYX |
Holdings
From latest NPORT-P, filed September 25th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| ABBVIE INC | Long | Equity-common | US | $329M | 2M | 18.21 |
| ACELYRIN INC | Long | Equity-common | US | $8M | 1M | 0.42 |
| AFFERENT PHARMACEUTICALS INC CONTINGENT VALUE RT 12/31/24 | Long | Equity-common | US | $383K | 2M | 0.02 |
| AFFERENT PHARMACEUTICALS INC SER C PC PP | Long | Equity-preferred | US | $19.16 | 2M | 0.00 |
| ALLAKOS INC | Long | Equity-common | US | $4M | 5M | 0.24 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $6M | 2M | 0.34 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $82M | 345K | 4.53 |
| ALTO NEUROSCIENCE INC | Long | Equity-common | US | $3M | 290K | 0.17 |
| ALX ONCOLOGY HOLDINGS INC | Long | Equity-common | US | $4M | 920K | 0.24 |
| AMGEN INC | Long | Equity-common | US | $171M | 513K | 9.43 |
| ANAPTYSBIO INC | Long | Equity-common | US | $15M | 423K | 0.81 |
| ANNEXON INC | Long | Equity-common | US | $3M | 502K | 0.18 |
| APELLIS PHARMACEUTICALS INC | Long | Equity-common | US | $13M | 334K | 0.73 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $23M | 470K | 1.27 |
| ARCELLX INC | Long | Equity-common | US | $24M | 384K | 1.31 |
| ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $68M | 132K | 3.76 |
| ARROWHEAD PHARMACEUTICALS INC | Long | Equity-common | US | $11M | 400K | 0.63 |
| ARVINAS INC | Long | Equity-common | US | $9M | 325K | 0.49 |
| ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $63M | 475K | 3.50 |
| ASTRIA THERAPEUTICS INC | Long | Equity-common | US | $11M | 979K | 0.63 |
| ASTRIA THERAPEUTICS INC WT | Long | Equity-common | US | $2M | 248K | 0.09 |
| AUTOLUS THERAPEUTICS LTD ADR (AUTOLUS THERAPEUTICS PLC) | Long | Equity-common | GB | $14M | 3M | 0.78 |
| AXSOME THERAPEUTICS INC | Long | Equity-common | US | $5M | 53K | 0.26 |
| BICYCLE THERAPEUTICS LTD ADR (BICYCLE THERAPEUTICS PLC) | Long | Equity-common | GB | $4M | 150K | 0.20 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $17M | 157K | 0.94 |
| BOUNDLESS BIO INC | Long | Equity-common | US | $36K | 9K | 0.00 |
| BOUNDLESS BIO INC (180 DAY LOCKUP) | Long | Equity-common | US | $731K | 190K | 0.04 |
| BRIDGEBIO PHARMA INC | Long | Equity-common | US | $6M | 245K | 0.35 |
| BRIDGEBIO PHARMA INC PIPE | Long | Equity-common | US | $10M | 394K | 0.56 |
| BRIGHT PEAK THERAPEUTICS SER B PC PP (BRIGHT PEAK THERAPEUTICS INC.) | Long | Equity-preferred | US | $3M | 2M | 0.17 |
| BRIGHT PEAK THERAPEUTICS SER C PC PP (BRIGHT PEAK THERAPEUTICS INC.) | Long | Equity-preferred | US | $996K | 874K | 0.06 |
| CARDURION PHARMACEUTICALS INC SER B PC PP | Long | Equity-preferred | US | $2M | 332K | 0.09 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $3M | 204K | 0.19 |
| CARGO THERAPEUTICS INC PIPE | Long | Equity-common | US | $3M | 170K | 0.16 |
| CARTESIAN THERAPEUTICS INC PIPE | Long | Equity-common | US | $3M | 168K | 0.15 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $16M | 426K | 0.90 |
| COGENT BIOSCIENCES INC | Long | Equity-common | US | $13M | 1M | 0.69 |
| CONTINEUM THERAPEUTICS INC CL A | Long | Equity-common | US | $5M | 265K | 0.29 |
| CRINETICS PHARMACEUTICALS INC | Long | Equity-common | US | $28M | 534K | 1.57 |
| CYTOKINETICS INC | Long | Equity-common | US | $47M | 796K | 2.60 |
| DENALI THERAPEUTICS INC | Long | Equity-common | US | $6M | 242K | 0.33 |
| DIANTHUS THERAPEUTICS INC | Long | Equity-common | US | $15M | 501K | 0.82 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $3M | 199K | 0.19 |
| ENDEAVOR BIOMEDICINES INC SERIES C PC PP | Long | Equity-preferred | US | $4M | 527K | 0.21 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $18M | 676K | 0.99 |
| ENLIVEN THERAPEUTICS INC CVR (NON-TRADABLE) | Long | Equity-common | US | $7.4 | 740K | 0.00 |
| ENLIVEN THERAPEUTICS INC PIPE | Long | Equity-common | US | $2M | 73K | 0.11 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $10M | 228K | 0.58 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $21M | 21M | 1.17 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $165M | 165M | 9.12 |
| FOG PHARMACEUTICALS INC SER D PC PP | Long | Equity-preferred | US | $1M | 239K | 0.08 |
| IMMUNOVANT INC | Long | Equity-common | US | $14M | 467K | 0.75 |
| INSMED INC | Long | Equity-common | US | $10M | 137K | 0.55 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $16M | 392K | 0.88 |
| KARTOS THERAPEUTICS INC SERIES C PC PP | Long | Equity-preferred | US | $3M | 531K | 0.19 |
| KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $12M | 249K | 0.69 |
| KYMERA THERAPEUTICS INC | Long | Equity-common | US | $2M | 43K | 0.11 |
| LARIMAR THERAPEUTICS INC | Long | Equity-common | US | $4M | 525K | 0.24 |
| LIFEMINE THERAPEUTICS INC SER C PP | Long | Equity-preferred | US | $4M | 2M | 0.22 |
| LONGBOARD PHARMACEUTICALS INC | Long | Equity-common | US | $10M | 286K | 0.53 |
| MADRIGAL PHARMACEUTICALS INC | Long | Equity-common | US | $23M | 82K | 1.28 |
| MERUS B.V. (MERUS NV) | Long | Equity-common | NL | $25M | 474K | 1.39 |
| MINERALYS THERAPEUTICS INC | Long | Equity-common | US | $4M | 302K | 0.21 |
| MONTE ROSA THERAPEUTICS INC | Long | Equity-common | US | $4M | 983K | 0.25 |
| MOONLAKE IMMUNOTHERAPEUTICS | Long | Equity-common | KY | $9M | 205K | 0.47 |
| NEUMORA THERAPEUTICS INC | Long | Equity-common | US | $12M | 902K | 0.64 |
| NEUROGENE INC | Long | Equity-common | US | $5M | 133K | 0.30 |
| NUVALENT INC-A | Long | Equity-common | US | $27M | 341K | 1.51 |
| ORIC PHARMACEUTICALS INC | Long | Equity-common | US | $7M | 582K | 0.36 |
| ORUKA THERAPEUTICS INC PIPE | Long | Equity-common | US | $4M | 673K | 0.22 |
| PERSPECTIVE THERAPEUTICS INC | Long | Equity-common | US | $4M | 309K | 0.23 |
| Q32 BIO INC | Long | Equity-common | US | $9M | 241K | 0.51 |
| RAPPORT THERAPEUTICS INC | Long | Equity-common | US | $304K | 13K | 0.02 |
| RAPPORT THERAPEUTICS INC 180-DAY LOCK-UP LINE | Long | Equity-common | US | $4M | 167K | 0.21 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $127M | 118K | 7.01 |
| REVOLUTION MEDICINES INC | Long | Equity-common | US | $17M | 375K | 0.95 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $27M | 190K | 1.50 |
| SAVARA INC | Long | Equity-common | US | $5M | 987K | 0.25 |
| SCHOLAR ROCK HOLDING CORP | Long | Equity-common | US | $4M | 449K | 0.23 |
| SCHOLAR ROCK HOLDING CORP WT 12/31/2025 PP | Long | Equity-common | US | $19K | 6K | 0.00 |
| SHATTUCK LABS INC | Long | Equity-common | US | $5M | 1M | 0.29 |
| SONOMA BIOTHERAPEUTICS INC SER B PFD PP | Long | Equity-preferred | US | $6M | 2M | 0.31 |
| SONOMA BIOTHERAPEUTICS INC SER B1 PFD PP | Long | Equity-preferred | US | $3M | 1M | 0.19 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $17M | 629K | 0.96 |
| STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $12M | 315K | 0.65 |
| T-KNIFE THERAPEUTICS INC SER B PC PP | Long | Equity-preferred | US | $2M | 1M | 0.12 |
| TANGO THERAPEUTICS INC | Long | Equity-common | US | $4M | 407K | 0.22 |
| TANGO THERAPEUTICS INC PIPE | Long | Equity-common | US | $3M | 318K | 0.17 |
| TECTONIC THERAPEUTIC INC PIPE | Long | Equity-common | US | $1M | 73K | 0.07 |
| TREELINE BIOSCIENCES SERIES A PC PP | Long | Equity-preferred | US | $427K | 48K | 0.02 |
| TYRA BIOSCIENCES INC | Long | Equity-common | US | $9M | 391K | 0.48 |
| UCB SA | Long | Equity-common | BE | $20M | 118K | 1.09 |
| VAXCYTE INC | Long | Equity-common | US | $47M | 599K | 2.61 |
| VERTEX PHARMACEUTICALS INC | Long | Equity-common | US | $85M | 172K | 4.72 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $41M | 717K | 2.26 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $22M | 1M | 1.20 |
| WUGEN INC CONV 10% 06/14/2025 PP | Long | Debt | US | $850K | – | 0.05 |
| WUGEN INC SER B PC PP | Long | Equity-preferred | US | $2M | 580K | 0.13 |
| XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $23M | 526K | 1.25 |
| ZENTALIS PHARMACEUTICALS LLC (ZENTALIS PHARMACEUTICALS INC) | Long | Equity-common | US | $3M | 667K | 0.14 |
Address
Fidelity Advisor Series VII
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
Oscar Munoz
Karen Peetz
Robert A Lawrence
Thomas A Kennedy
Bettina Doulton
Vicki L Fuller
Vijay Advani
Thomas P Bostick
Patricia L Kampling
Donald F Donahue
Michael E Wiley
Susan Tomasky
David M Thomas
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
INTERCONTINENTAL EXCHANGE INC
REFINITIV US HOLDINGS INC
Custodians
STANDARD CHARTERED BANK
BNP PARIBAS GREECE
SSB GMBH GERMANY - CBF
EUROCLEAR
BANCO NACIONAL DE MEXICO SA
SEB NORWAY
STATE STREET SERVICES (UK) LIMITED
HSBC - JAPAN
BNP PARIBAS NETHERLANDS
CITIBANK SINGAPORE
BNP PARIBAS FRANCE
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
Citibank Europe Plc
STATE STREET TRUST COMPANY CANADA
BNP PARIBAS BELGIUM
STATE STREET BANK AND TRUST COMPANY
INTESA SANPAOLO SPA
HSBC AUSTRALIA
CITIBANK N.A.
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
WELLS FARGO and CO
GOLDMAN SACHS GROUP INC (THE)
BARCLAYS PLC
MORGAN STANLEY
ROYAL BANK OF CANADA
BANK OF AMERICA CORPORATION
UBS GROUP AG
CITIGROUP INC
JPMORGAN CHASE and CO
JEFFERIES FINANCIAL GROUP INC